Bausch + Lomb: Bausch + Lomb (BLCO) Reports Q1 Loss, Misses Revenue Estimates
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of -333.33% and 0.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Read full article »
Bausch and Lomb is a New Jersey-based medical device company that manufactures and supplies ophthalmic products and accessories for the healthcare industry.
Read more